208 related articles for article (PubMed ID: 18755987)
1. 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.
O'Brien JJ; Spinelli SL; Tober J; Blumberg N; Francis CW; Taubman MB; Palis J; Seweryniak KE; Gertz JM; Phipps RP
Blood; 2008 Nov; 112(10):4051-60. PubMed ID: 18755987
[TBL] [Abstract][Full Text] [Related]
2. 15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis.
O'Brien JJ; Baglole CJ; Garcia-Bates TM; Blumberg N; Francis CW; Phipps RP
J Thromb Haemost; 2009 Jan; 7(1):182-9. PubMed ID: 18983509
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
[TBL] [Abstract][Full Text] [Related]
4. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
[TBL] [Abstract][Full Text] [Related]
6. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
Liu X; Yu H; Yang L; Li C; Li L
Eur J Cell Biol; 2012 Aug; 91(8):654-61. PubMed ID: 22560326
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
Olmos G; Conde I; Arenas I; Del Peso L; Castellanos C; Landazuri MO; Lucio-Cazana J
Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
Wang JJ; Mak OT
Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):104-11. PubMed ID: 21396480
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
Ray DM; Akbiyik F; Phipps RP
J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
[TBL] [Abstract][Full Text] [Related]
10. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state.
Katura T; Moriya T; Nakahata N
Mol Pharmacol; 2010 Apr; 77(4):601-11. PubMed ID: 20086036
[TBL] [Abstract][Full Text] [Related]
11. 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells.
Cho WH; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2006 Oct; 31(10):1247-54. PubMed ID: 17006759
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
[TBL] [Abstract][Full Text] [Related]
13. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.
Akbiyik F; Ray DM; Gettings KF; Blumberg N; Francis CW; Phipps RP
Blood; 2004 Sep; 104(5):1361-8. PubMed ID: 15130939
[TBL] [Abstract][Full Text] [Related]
14. 15-Deoxy-Δ12,14-prostaglandin J2 induces PPARγ- and p53-independent apoptosis in rabbit synovial cells.
Sakaba Y; Awata H; Morisugi T; Kawakami T; Sakudo A; Tanaka Y
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():1-13. PubMed ID: 24680891
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors and 15-deoxy-Delta12,14-prostaglandin J2 synergistically induce apoptosis.
Koyama M; Izutani Y; Goda AE; Matsui TA; Horinaka M; Tomosugi M; Fujiwara J; Nakamura Y; Wakada M; Yogosawa S; Sowa Y; Sakai T
Clin Cancer Res; 2010 Apr; 16(8):2320-32. PubMed ID: 20371690
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy.
Winnett G; van Hagen D; Schrey M
Int J Cancer; 2003 Feb; 103(5):600-5. PubMed ID: 12494466
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock.
Kaplan JM; Cook JA; Hake PW; O'Connor M; Burroughs TJ; Zingarelli B
Shock; 2005 Jul; 24(1):59-65. PubMed ID: 15988322
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
Yamamoto Y; Fujita M; Koma H; Yamamori M; Nakamura T; Okamura N; Yagami T
Biochem Biophys Res Commun; 2011 Jul; 410(3):563-7. PubMed ID: 21683069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
